Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,253 | -7,589 | 0 | N/A | N/A |
| Depreciation Amortization | 1 | N/A | 0 | N/A | N/A |
| Other Working Capital | 871 | -1,112 | 0 | N/A | N/A |
| Other Operating Activity | 1,229 | 3,168 | 0 | 0 | 0 |
| Operating Cash Flow | $-7,153 | $-5,533 | $0 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -55 | N/A | 0 | N/A | N/A |
| Investing Cash Flow | $-55 | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 20,745 | 0 | 0 | 0 |
| Financing Cash Flow | $6 | $20,745 | $0 | $N/A | $N/A |
| Beginning Cash Position | 15,212 | N/A | 0 | N/A | N/A |
| End Cash Position | 8,010 | 15,212 | 0 | N/A | N/A |
| Net Cash Flow | $-7,201 | $15,212 | $0 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,153 | -5,533 | 0 | N/A | N/A |
| Capital Expenditure | -55 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -7,208 | -5,533 | 0 | 0 | 0 |